Skip to Content

Cefpodoxime Pregnancy and Breastfeeding Warnings

Cefpodoxime is also known as: Vantin

Medically reviewed on November 9, 2017

Cefpodoxime Pregnancy Warnings

Cefpodoxime has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of embryotoxicity or teratogenicity. There are no controlled data in human pregnancy. Cefpodoxime should only be given during pregnancy when need has been clearly established.

See references

Cefpodoxime Breastfeeding Warnings

Cefpodoxime is excreted into human milk in small amounts. Adverse effects in the nursing infant are unlikely. Other cephalosporins have been classified as compatible with breast-feeding by the American Academy of Pediatrics.

See references

References for pregnancy information

  1. "Product Information. Vantin (cefpodoxime)." Pharmacia and Upjohn, Kalamazoo, MI.

References for breastfeeding information

  1. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  2. "Product Information. Vantin (cefpodoxime)." Pharmacia and Upjohn, Kalamazoo, MI.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide